Chronic imipramine treatment induces downregulation of alpha-2 receptors in rat's locus coeruleus and A2 region of the tractus solitarius.
Imipramine is an effective antidepressant agent that blocks the reuptake of monoamines. In order to understand some of its basic mechanisms of action, we investigated the effects of chronic imipramine administration (10 mg/kg, i.p.; 21 days) on the alpha-2 receptor population of several brain sites. Alpha-2 receptor density was estimated by in vitro autoradiography using [3H]Idazoxan. The densitometric analysis revealed a decreased receptor density in the A2 region of the tractus solitarius (20%) and locus coeruleus (16%). No changes were observed in the amygdala, pyriform cortex, periacueductal gray and the bed nucleus of the stria terminalis. These results suggest that chronic imipramine treatment selectively modulates the alpha-2 receptor population localized in the brain stem norepinephrine-rich nuclei and not in the population present on limbic structures innervated by noradrenergic terminal projections. The possible physiological consequences of this selective modulation of alpha-2 receptors are discussed.
Jiménez-Rivera
C A
CA
Department of Physiology, Universidad Central del Caribe Medical School, Bayamón, Puerto Rico 00956.
Segarra
O
O
Santacana
G
G
Hoffman
T
T
Savage
D D
DD
Weiss
G K
GK
D000317:Adrenergic alpha-Antagonists / Q000378:metabolism; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000494:pharmacology*; D001345:Autoradiography; D003720:Densitometry; D004146:Dioxanes / Q000378:metabolism; D015536:Down-Regulation / Q000187:drug effects; D019329:Idazoxan; D007093:Imidazoles / Q000378:metabolism; D007099:Imipramine / Q000008:administration & dosage / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D008125:Locus Coeruleus / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D018341:Receptors, Adrenergic, alpha-2 / Q000378:metabolism*; D017552:Solitary Nucleus / Q000187:drug effects / Q000378:metabolism*
D000317:Adrenergic alpha-Antagonists; D000929:Antidepressive Agents, Tricyclic; D004146:Dioxanes; D007093:Imidazoles; D018341:Receptors, Adrenergic, alpha-2; D007099:Imipramine; D019329:Idazoxan